Watchlist Price Alert

Scinai Immunotherapeutics... (SCNI)

NASDAQ: SCNI · Real-Time Price · USD

2.54

-0.71 (-21.85%)

At close: Jun 06, 2025, 3:59 PM

2.49

-1.97%

After-hours: Jun 06, 2025, 05:46 PM EDT

Scinai Immunotherapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	4.87M	14.07M	17.37M	2.93M	20.98M	20.29M	20.51M	4.08M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	2.5M
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	532.08K
Other Long-Term Assets	n/a	n/a	n/a	147.16K	150.16K	197.88K	252.9K	124.07K
Receivables	366K	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	140K	250K	241K	71.25K	101.06K	102.42K	911.89K	198.3K
Total Current Assets	5.45M	14.37M	17.84M	3.31M	21.17M	20.55M	21.64M	6.78M
Property-Plant & Equipment	12.03M	12.7M	14.19M	14.25M	12.19M	7.55M	1.58M	374.53K
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	12.03M	12.7M	14.19M	14.4M	12.34M	7.75M	1.84M	1.03M
Total Assets	17.47M	27.07M	32.04M	17.71M	33.52M	28.3M	23.48M	7.82M
Account Payables	535K	716K	999K	581.19K	4.94M	5.54M	1.79M	178.05K
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	n/a	18.8M	n/a	n/a	n/a	n/a
Other Current Liabilities	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-190
Total Current Liabilities	1.78M	2.34M	2.44M	19.97M	5.49M	5.83M	1.98M	356.88K
Long-Term Debt	19.37M	20.08M	27.16M	n/a	35.84M	25.23M	n/a	n/a
Other Long-Term Liabilities	96K	5.33M	n/a	382.69K	9.06M	5.59M	5.33M	809.54K
Total Long-Term Liabilities	20.26M	26.49M	28.61M	2.28M	46.87M	30.82M	5.33M	809.54K
Total Liabilities	22.04M	28.83M	31.05M	22.25M	52.36M	36.65M	7.31M	1.17M
Total Debt	20.56M	21.54M	28.98M	20.9M	38.02M	25.23M	n/a	n/a
Common Stock	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Retained Earnings	-122.33M	-115.83M	-110.04M	-101.05M	-92.76M	-56.46M	-35.47M	-23.07M
Comprehensive Income	-1.74M	-2.01M	-2.06M	0.00	n/a	0.00	n/a	374.01K
Shareholders Equity	-4.57M	-1.76M	982K	-4.54M	-18.84M	-8.35M	16.17M	6.65M
Total Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	2.51M